SNPnexus: an enhanced web platform for large-scale and multi-sample variant analysis (2025 update)

Clinical Snapshot

Key Findings

• P Value: Not applicable — descriptive software update article with no hypothesis testing

• Effect Size: Not formally quantified; the increase in query capacity from the previous limit to 150,000 variants per query represents the primary measurable performance metric reported

• Primary Outcome: Successful re-engineering of the SNPnexus platform with expanded query capacity (up to 150,000 variants per query), multi-sample comparative analysis functionality, updated GRCh37/GRCh38 annotation datasets, pre-annotation filtering, interactive visualisations, and optional user account features

• Nnt Or Sensitivity: Not applicable — no diagnostic accuracy, therapeutic efficacy, or prognostic data are presented; annotation sensitivity and specificity for pathogenicity prediction are not benchmarked

• Confidence Interval: Not reported — no statistical analyses were performed

Clinical Application

High feasibility for adoption in research settings given free, web-based access with no software installation requirements. Clinical laboratory adoption requires careful consideration of data governance, particularly for patient-identifiable genomic data uploaded to external web servers. Integration into accredited clinical genomics workflows (e.g., NATA-accredited laboratories) would require validation against laboratory-specific quality standards. The 150,000-variant capacity supports whole-exome sequencing panels but may still be limiting for whole-genome sequencing applications generating millions of variants. SNPnexus is directly relevant to Australian genomic medicine practice. The Australian Genomics Health Alliance and state-based clinical genomics services (e.g., Victorian Clinical Genetics Services, Genomics Queensland) could utilise this platform for research-grade variant annotation. The tool is not TGA-regulated as a medical device in its current form, as it functions as a research annotation aid rather than a diagnostic decision-support system. PBS implications are indirect — improved variant prioritisation tools may support more efficient diagnostic pathways for conditions with PBS-listed genomic testing (e.g., hereditary cancer panels, pharmacogenomic testing). RACGP guidelines on genomic medicine emphasise the importance of validated, evidence-based variant interpretation tools; SNPnexus would require independent validation before being recommended in primary care genomics contexts. Australian researchers should note that population allele frequency data may have limited representation of Aboriginal and Torres Strait Islander genomic diversity, which is a critical consideration for equitable genomic medicine. Clinical genomicists, molecular pathologists, genetic counsellors, and translational researchers performing variant interpretation for rare disease diagnosis, cancer genomics, pharmacogenomics, and population genetics studies; applicable to both research and clinical laboratory settings

Abstract

SNPnexus is a long-standing web-based platform for the functional annotation and prioritization of genetic variants. Since its previous release, SNPnexus has undergone substantial backend re-engineering resulting in major performance improvements and a complete restructuring of the underlying datasets. A redesigned interface now enables larger queries and multi-sample analysis enabling comparative workflows such as identifying shared pathogenic variants in disease cohorts and divergent mutations in cancer evolution studies. SNPnexus increased its capacity to 150 000 variants per query and introduced pre-annotation filters that allow users to restrict analyses to selected genes or genomic regions, improving efficiency while enabling targeted interrogation of high-priority targets. SNPnexus integrates updated and expanded annotations across both GRCh37 and GRCh38, covering genomic consequences, in silico pathogenicity predictions, population allele frequencies, evolutionary conservation, regulatory elements, biological pathways, and clinical associations. The refreshed result interface provides interactive visualizations for single-sample and cohort-level outputs, together with advanced filtering and export options. Optional user accounts now support query history and real-time job monitoring while preserving full, unregistered access for all users. SNPnexus remains free and open to all users without login requirements at https://snpnexus.org/.

References

1. 1.Oscanoa, J., Zhu, Q., Gadaleta, E., & Chelala, C. (2026). SNPnexus: an enhanced web platform for large-scale and multi-sample variant analysis (2025 update). Nucleic Acids Research. Advance online publication. https://doi.org/10.1093/nar/gkaf389